AURORA CANNABIS INC (ACB.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:ACB - CA05156X8504 - Common Stock
ACB.CA Key Statistics, Chart & Performance
The current stock price of ACB.CA is 5.92 CAD. In the past month the price decreased by -5.43%. In the past year, price increased by 6.47%.
ACB.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.97 | 3.87B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.51B | ||
| CRON.CA | CRONOS GROUP INC | 25 | 1.44B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.21 | 893.88M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 5.12 | 634.32M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 637.44M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 586.80M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 550.96M | ||
| TSND.CA | TERRASCEND CORP | N/A | 394.03M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 16.3 | 380.55M | ||
| HITI.CA | HIGH TIDE INC | N/A | 323.70M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 314.33M |
Related stock screener links
About ACB.CA
Company Profile
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
Company Info
AURORA CANNABIS INC
2207 90B Street Sw
Leduc ALBERTA T9E 0V6 CA
CEO: Miguel Martin
Employees: 1073
Phone: 16043625207
AURORA CANNABIS INC / ACB.CA FAQ
Can you describe the business of AURORA CANNABIS INC?
Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. The company is headquartered in Leduc, Alberta and currently employs 1,101 full-time employees. The company went IPO on 2007-09-26. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally. The Company’s segments include Cannabis and Plant Propagation. The firm's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, IndiMed and CraftPlant. The firm also holds a 50.1% controlling interest in Bevo Farms Ltd., a supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.
What is the stock price of AURORA CANNABIS INC today?
The current stock price of ACB.CA is 5.92 CAD. The price increased by 0.51% in the last trading session.
Does ACB stock pay dividends?
ACB.CA does not pay a dividend.
What is the ChartMill rating of AURORA CANNABIS INC stock?
ACB.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is AURORA CANNABIS INC (ACB.CA) stock traded?
ACB.CA stock is listed on the Toronto Stock Exchange exchange.
What is the analyst forecast for ACB.CA stock?
9 analysts have analysed ACB.CA and the average price target is 8.08 CAD. This implies a price increase of 36.55% is expected in the next year compared to the current price of 5.92.
ACB.CA Technical Analysis
ACB.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ACB.CA. While ACB.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
ACB.CA Financial Highlights
Over the last trailing twelve months ACB.CA reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS increased by 57.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.78% | ||
| ROE | -11.07% | ||
| Debt/Equity | 0.07 |
ACB.CA Forecast & Estimates
9 analysts have analysed ACB.CA and the average price target is 8.08 CAD. This implies a price increase of 36.55% is expected in the next year compared to the current price of 5.92.
For the next year, analysts expect an EPS growth of -1574.6% and a revenue growth 11.1% for ACB.CA